1. Service Overview & Global Regulatory Compliance Framework
As a China-based professional biopharmaceutical plant design and construction expert, we deliver full-lifecycle, process-driven EPC solutions fully compliant with NMPA, FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 quality risk management and data integrity standards. Integrating specialized design, sanitary construction, system integration and GMP commissioning services, our portfolio covers greenfield plant development, brownfield compliance upgrading, pilot-scale process workshop construction and commercial-grade biomanufacturing facility delivery for monoclonal antibodies, recombinant proteins, viral vectors and vaccines. Domestic and international biopharma projects often encounter typical pain points including process-facility disconnection, non-standard sanitary construction execution, incomplete cross-standard compliance design, chaotic on-site management and insufficient international audit-ready documentation. Combining mature local construction implementation experience and global regulatory expertise, we provide highly cost-effective, schedule-stabilized and fully inspection-ready plant engineering solutions for domestic biotech enterprises, cross-border investors and Asia-Pacific biopharmaceutical industrial projects.
2. Core Technical Philosophy & Sino-Global Compliance Advantages
Guided by quality-by-design and risk-based full-process control, our design and construction expertise embeds bioprocess characteristics and dual-standard compliance requirements into every engineering execution link. All cleanroom classification, functional zoning, personnel/material unidirectional flow arrangement, HVAC pressure cascade and ASME BPE-compliant sanitary piping layout are optimized based on product critical quality attributes (CQAs) and critical process parameters (CPPs). We strictly implement unified GMP construction specifications, zero-dead-leg sanitary welding standards and ALCOA+ data integrity principles, realizing intrinsic contamination control and process reproducibility at the facility level. Different from ordinary general construction teams lacking biopharma professionalism, our specialized biotech engineering system perfectly balances domestic construction practicability and international regulatory adaptability, effectively reducing post-construction modification rates, eliminating compliance loopholes and maintaining long-term dual-standard inspection readiness for biomanufacturing plants.
3. Four Core Service Modules & Standard Project Deliverables
Our integrated biopharmaceutical plant design and construction system consists of four synergistic full-chain functional modules covering end-to-end project delivery: dual-standard regulatory design module, process-centric sanitary layout module, GMP standardized construction module, and full CQV compliance handover module. The dual-standard design module conducts multi-standard gap analysis, master plant planning, BIM 3D spatial optimization and P&ID systematic design, delivering URS and DQ documents compatible with both Chinese and international regulatory systems. The sanitary layout module optimizes biomanufacturing workflow zoning, closed aseptic operation layout and utility system matching to minimize open exposure and cross-contamination risks. The standardized construction module implements classified cleanroom engineering, sanitary system installation, MEP utility deployment and on-site GMP quality supervision with unified execution standards. The CQV handover module completes FAT/SAT testing, full IQ/OQ/PQ validation and bilingual audit dossier sorting. Standard deliverables include complete engineering drawings, construction quality records, validation packages and as-built technical archives.
4. Industrial Application & Full Lifecycle Localized Support
Our professional design and construction services are widely applied in domestic biopharmaceutical industrial parks, cross-border invested biomanufacturing bases, clinical pilot process platforms and flexible multi-product CMO facilities in China and the Asia-Pacific region. All project solutions adopt modular, scalable and future-proof architecture, reserving flexible expansion and process intensification interfaces to support subsequent capacity upgrading and new biotherapeutic pipeline iteration. We provide localized full-lifecycle technical support including early-stage scheme consultation, on-site construction management, engineering quality verification, post-handover operational guidance and long-term regulatory update adaptation. As a reliable China-based expert team, we deliver high-quality, cost-efficient and globally compliant plant engineering outcomes, helping clients accelerate facility commissioning, shorten product industrialization cycles and enhance market competitiveness in innovative biopharmaceutical commercialization.
